Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03023449 · ClinicalTrials.gov registry record · Phase 2

Diffuse Optical Monitoring With Inhaled Nitric Oxide

A Phase 2 study of Stroke, sponsored by Steven Messe.

Active
Registry status
Phase 2
Development phase
40
Enrollment target
1
Study location

NCT03023449: Active Phase 2 study of Stroke, sponsored by Steven Messe.

NCT03023449 is a Phase 2 study of Stroke that is active but no longer recruiting, run by Steven Messe. The registered enrollment target is 40 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03023449, a Phase 2 study of Stroke, is active but no longer recruiting, sponsored by Steven Messe.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study is a non-randomized, Phase 2 clinical trial designed to measure the cerebral blood flow (CBF) response to inhaled nitric oxide in acute ischemic stroke patients and healthy subjects. The monitoring is a 35 minute session during which cerebral hemodynamics will be monitored with both diffuse correlation spectroscopy (DCS) and transcranial doppler ultrasonography (TCD) while blood pressure, heart rate, cardiac output, respiratory rate, end oxygen saturation, and inhaled nitric oxide (NO)/nitrogen dioxide (NO2) concentration, are continuously monitored.

Conditions Studied

Stroke

Interventions

  • DRUG Nitric Oxide

Study Locations (1)

Pennsylvania

  • Hospital of the University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2017-04-04
Est. Completion 2026-07
Phase Phase 2

Sponsor

Steven Messe

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03023449

The ClinicalTrials.gov registry entry for NCT03023449 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Steven Messe, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Nitric Oxide is the first listed.

NCT03023449 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03023449 about?

NCT03023449 is a clinical study titled "Diffuse Optical Monitoring With Inhaled Nitric Oxide". This study is a non-randomized, Phase 2 clinical trial designed to measure the cerebral blood flow (CBF) response to inhaled nitric oxide in acute ischemic stroke patients and healthy subjects. The monitoring is a 35 minute session during which cerebral hemodynamics will be monitored with both diffu...

What is the current status of trial NCT03023449?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2017-04-04. Estimated completion is 2026-07.

What conditions does trial NCT03023449 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT03023449?

The interventions under investigation include: Nitric Oxide (DRUG).

Who is sponsoring clinical trial NCT03023449?

This trial is sponsored by Steven Messe, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03023449 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Stroke

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.